<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2013-1504</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-1320</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Интерстициальное поражение легких как внесуставное проявление ревматоидного артрита (лекция)</article-title><trans-title-group xml:lang="en"><trans-title>Interstitial lung disease as an extra-articular manifestation of rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Bestaev</surname><given-names>David Vladimirovich</given-names></name><name name-style="western" xml:lang="en"><surname>Bestaev</surname><given-names>David Vladimirovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>докторант кафедры ревматологии ФППОВ; научный сотрудник канд. мед. наук</p></bio><bio xml:lang="en"><p>doktorant kafedry revmatologii FPPOV; nauchnyy sotrudnik kand. med. nauk</p></bio><email xlink:type="simple">davidbestaev@rambler.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каратеев</surname><given-names>Дмитрий Евгеньевич</given-names></name><name name-style="western" xml:lang="en"><surname>Karateev</surname><given-names>D E</given-names></name></name-alternatives><bio xml:lang="ru"><p>заместитель директора д-р мед. наук</p></bio><bio xml:lang="en"><p>zamestitel' direktora d-r med. nauk</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Насонов</surname><given-names>Евгений Львович</given-names></name><name name-style="western" xml:lang="en"><surname>Nasonov</surname><given-names>E L</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор академик РАМН</p></bio><bio xml:lang="en"><p>direktor akademik RAMN</p></bio><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>15</day><month>06</month><year>2013</year></pub-date><volume>51</volume><issue>3</issue><issue-title>№3 (2013)</issue-title><fpage>290</fpage><lpage>295</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Bestaev D.V., Каратеев Д.Е., Насонов Е.Л., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Bestaev D.V., Каратеев Д.Е., Насонов Е.Л.</copyright-holder><copyright-holder xml:lang="en">Bestaev D.V., Karateev D.E., Nasonov E.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/1320">https://rsp.mediar-press.net/rsp/article/view/1320</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Ревматология: Клинические рекомендации. Под ред. акад. PAMH Е.Л. Насонова. 2-е изд., испр. и доп. М.: ГЭОТАР-Медиа, 2010;90—230.&lt;/p&gt;&lt;p&gt;Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277—89.&lt;/p&gt;&lt;p&gt;Ellman P., Ball R.E. Rheumatoid disease with joint and pulmonary manifestations. Br Med J 1948;2:816—20.&lt;/p&gt;&lt;p&gt;Cudkowicz L., Madoff I.M., Abelmann W.H. Rheumatoid lung disease. A case report which includes respiratory function studies and a lung biopsy. Br J Dis Chest 1961;55:35—40.&lt;/p&gt;&lt;p&gt;Aronoff A., Bywaters E.G., Fearnley G.R. Lung lesions in rheumatoid arthritis. Br Med J 1955;2:228—32.&lt;/p&gt;&lt;p&gt;Talbott J.A., Calkins E. Pulmonary involvement in rheumatoid arthritis. JAMA 1964;189:911—3.&lt;/p&gt;&lt;p&gt;Frank S.T., Weg J.G., Harkleroad L.E., Fitch R.F. Pulmonary dysfunction in rheumatoid disease. Chest 1973;63:27—34.&lt;/p&gt;&lt;p&gt;Popper M.S., Bogdonoff M.L., Hughes R.L. Interstitial rheumatoid lung disease. A reassessment and review of the literature. Chest 1972;62:243—50.&lt;/p&gt;&lt;p&gt;Popp W., Rauscher H., Ritschka L. et al. Prediction of interstitial lung involvement in rheumatoid arthritis. The value of clinical data, chest roentgenogram, lung function, and serologic parameters. Chest 1992;102:391—4.&lt;/p&gt;&lt;p&gt;Cervantes-Perez P., Toro-Perez A.H., Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA 1980;243:1715—9.&lt;/p&gt;&lt;p&gt;Fujii M., Adachi S., Shimizu T. et al. Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thome Imaging 1993;8:54—62.&lt;/p&gt;&lt;p&gt;Dawson J.K., Fewins H.E., Desmond J. et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56:622—7.&lt;/p&gt;&lt;p&gt;Rajasekaran B.A., Shovlin D., Lord P., Kelly C.A. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 2001;40:1022—5.&lt;/p&gt;&lt;p&gt;Horton M.R. Rheumatoid arthritis associated interstitial lung disease. Crit Rev Comput Tomogr 2004;45:429—40.&lt;/p&gt;&lt;p&gt;Bongartz T., Nannini C., Medina-Velasquez Y.F. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthr Rheum 2010;62:1583—91.&lt;/p&gt;&lt;p&gt;Jurik A.G., Davidsen D., Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol 1982;11:217—24.&lt;/p&gt;&lt;p&gt;Saag K.G., Kolluri S., Koehnke R.K. et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthr Rheum 1996;39:1711—9.&lt;/p&gt;&lt;p&gt;Banks J., Banks C., Cheong B. et al. An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med 1992;85:795—806.&lt;/p&gt;&lt;p&gt;Gochuico B.R., Avila N.A., Chow C.K. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168:159—66.&lt;/p&gt;&lt;p&gt;Aubart F., Crestani B., Nicaise-Roland P. et al. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with cooccurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 2011;38:979—82.&lt;/p&gt;&lt;p&gt;Anaya J.M., Diethelm L., Ortiz L.A. et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthr Rheum 1995;24:242—54.&lt;/p&gt;&lt;p&gt;Shidara K., Hoshi D., Inoue E. et al. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol 2010;20:280—6.&lt;/p&gt;&lt;p&gt;Bilgici A., Ulusoy H., Kuru O. et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 2005;25:429—35.&lt;/p&gt;&lt;p&gt;Tanaka N., Kim J.S., Newell J.D. et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004;232:81 —91.&lt;/p&gt;&lt;p&gt;Sakaida H. IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease. Ryumachi 1995;35:671—7.&lt;/p&gt;&lt;p&gt;Alexiou I., Germenis A., Koutroumpas A. et al. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008;27:511—3.&lt;/p&gt;&lt;p&gt;Scott T.E., Wise R.A., Hochberg M.C., Wigley F.M. HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. Am J Med 1987;82:765—71.&lt;/p&gt;&lt;p&gt;Charles PJ., Sweatman M.C., Markwick J.R., Maini R.N. HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Dis Markers 1991;9:97—101.&lt;/p&gt;&lt;p&gt;Tanoue L.T. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 1998;19:667—85.&lt;/p&gt;&lt;p&gt;Albano S.A., Santana-Sahagun F., Weisman M.H. Cigarette smoking and rheumatoid arthritis. Sem Arthr Rheum 2001;31:146—59.&lt;/p&gt;&lt;p&gt;Jawaheer D., Gregersen P.K. Rheumatoid arthritis. The genetic components. Rheum Dis Clin North Am 2002;28:1—15.&lt;/p&gt;&lt;p&gt;Klareskog L., Stolt P., Lundberg K. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr Rheum 2006;54:38—46.&lt;/p&gt;&lt;p&gt;Makrygiannakis D., Hermansson M., Ulfgren A.K. et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488—92.&lt;/p&gt;&lt;p&gt;De Rycke L., Nicholas A.P., Cantaert T. et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deаminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthr Rheum 2005;52:2323—30.&lt;/p&gt;&lt;p&gt;Bongartz T., Cantaert T., Atkins S.R. et al. Citrullination in extraarticular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2007;46:70—5.&lt;/p&gt;&lt;p&gt;Stolt P., Bengtsson C., Nordmark B. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835—41.&lt;/p&gt;&lt;p&gt;Ayhan-Ardic F.F., Oken O., Yorgancioglu Z.R. et al. Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 2006;25:213—8.&lt;/p&gt;&lt;p&gt;Gabriel S.E., Crowson C.S., Kremers H.M. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthr Rheum 2003;48:54—8.&lt;/p&gt;&lt;p&gt;Hyland R.H., Gordon D.A., Broder I. et al. A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis. J Rheumatol 1983;10:395—405.&lt;/p&gt;&lt;p&gt;Gabbay E., Tarala R., Will R. et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156(2 Pt 1):528—35.&lt;/p&gt;&lt;p&gt;Sugiyama Y., Ohno S., Kano S. et al. Diffuse panbron-chiolitis and rheumatoid arthritis: a possible correlation with HLA-B54. Intern Med 1994;33:612—4.&lt;/p&gt;&lt;p&gt;Hillarby M.C., McMahon M.I., Grennan D.M. et al. HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 1993;32:794—7.&lt;/p&gt;&lt;p&gt;Michalski J.P., McCombs C.C., Scopelitis E. et al. Alpha1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthr Rheum 1986;29:586—91.&lt;/p&gt;&lt;p&gt;Turesson C., Matteson E.L., Colby TV. et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthr Rheum 2005;52:73—9.&lt;/p&gt;&lt;p&gt;Michel J.J., Turesson C., Lemster B. et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthr Rheum 2007;56:43—57.&lt;/p&gt;&lt;p&gt;Atkins S.R., Turesson C., Myers J.L. et al. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthr Rheum 2006;54:635-41.&lt;/p&gt;&lt;p&gt;Song J.W., Do K.H., Kim M.Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136:23-30.&lt;/p&gt;&lt;p&gt;Ancochea J., Giron R.M., Lopez-Botet M. Production of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages from patients with rheumatoid arthritis and interstitial pulmonary disease. Arch Bronchoreum 1997;33:335-40.&lt;/p&gt;&lt;p&gt;Horie S., Nakada K., Minota S., Kano S. High proliferative potential colony-forming cells (HPP-CFCs) in the peripheral blood of rheumatoid arthritis patients with interstitial lung disease. Scand J Rheumatol 2003;32:273-6.&lt;/p&gt;&lt;p&gt;Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14:272-80.&lt;/p&gt;&lt;p&gt;Kim E.J., Elicker B.M., Maldonado F. et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35:1322-8.&lt;/p&gt;&lt;p&gt;Lee H.K., Kim D.S., Yoo B. et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005;127:2019-27.&lt;/p&gt;&lt;p&gt;Luqmani R., Hennell S., Estrach C. et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.&lt;/p&gt;&lt;p&gt;Roschmann R.A., Rothenberg R.J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthr Rheum 1987;16:174-85.&lt;/p&gt;&lt;p&gt;Rajasekaran A., Shovlin D., Saravanan V. et al. Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. J Rheumatol 2006;33:1250-3.&lt;/p&gt;&lt;p&gt;Provenzano G. Asymptomatic pulmonary involvement in RA. Thorax 2002;57:187-8.&lt;/p&gt;&lt;p&gt;Dawson J.K., Fewins H.E., Desmond J. et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002:61:517-21.&lt;/p&gt;&lt;p&gt;Shannon T.M., Gale M.E. Noncardiac manifestations of rheumatoid arthritis in the thorax. J Thorac Imaging 1992;7:19-29.&lt;/p&gt;&lt;p&gt;McDonagh J., Greaves M., Wright A.R. et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-22.&lt;/p&gt;&lt;p&gt;Metafratzi Z.M., Georgiadis A.N., Ioannidou C.V. et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007;36:338-44.&lt;/p&gt;&lt;p&gt;Akira M., Sakatani M., Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 1999;23:941-8.&lt;/p&gt;&lt;p&gt;Kim E.J., Collard H.R., King T.E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009;136:1397-405.&lt;/p&gt;&lt;p&gt;Okuda Y., Takasugi K., Kurata N., Takahara J. Bronchoalveolar lavage fluid analysis in rheumatoid arthritis. Ryumachi 1993;33:302-9.&lt;/p&gt;&lt;p&gt;Gilligan D.M., O’Connor C.M., Ward K. et al. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 1990;45:591-6.&lt;/p&gt;&lt;p&gt;Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175:705-11.&lt;/p&gt;&lt;p&gt;Yousem S.A., Colby T.V., Carrington C.B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770-7.&lt;/p&gt;&lt;p&gt;Kinoshita F., Hamano H., Harada H. et al. Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respir Med 2004;98:1131-7.&lt;/p&gt;&lt;p&gt;Tsuchiya Y., Takayanagi N., Sugiura H. et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Euro Respir J 2011;37:1411-7.&lt;/p&gt;&lt;p&gt;Pratt D.S., Schwartz M.I., May J.I., Dreisin R.B. Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax 1979;34:587-93.&lt;/p&gt;&lt;p&gt;Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 1988;93:114-8.&lt;/p&gt;&lt;p&gt;Hubbard R., Venn A. The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford) 2002;41:676-9.&lt;/p&gt;&lt;p&gt;Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.&lt;/p&gt;&lt;p&gt;Saravanan V., Kelly C.A. Survival in fibrosing alveolitis associated with rheumatoid arthritis is better than cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 2003;42:603-4.&lt;/p&gt;&lt;p&gt;Malik S., Saravanan V., Kelly C. Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management. Int J Clin Rheum 2012;7:297-308.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Ревматология: Клинические рекомендации. Под ред. акад. PAMH Е.Л. Насонова. 2-е изд., испр. и доп. М.: ГЭОТАР-Медиа, 2010;90—230.&lt;/p&gt;&lt;p&gt;Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277—89.&lt;/p&gt;&lt;p&gt;Ellman P., Ball R.E. Rheumatoid disease with joint and pulmonary manifestations. Br Med J 1948;2:816—20.&lt;/p&gt;&lt;p&gt;Cudkowicz L., Madoff I.M., Abelmann W.H. Rheumatoid lung disease. A case report which includes respiratory function studies and a lung biopsy. Br J Dis Chest 1961;55:35—40.&lt;/p&gt;&lt;p&gt;Aronoff A., Bywaters E.G., Fearnley G.R. Lung lesions in rheumatoid arthritis. Br Med J 1955;2:228—32.&lt;/p&gt;&lt;p&gt;Talbott J.A., Calkins E. Pulmonary involvement in rheumatoid arthritis. JAMA 1964;189:911—3.&lt;/p&gt;&lt;p&gt;Frank S.T., Weg J.G., Harkleroad L.E., Fitch R.F. Pulmonary dysfunction in rheumatoid disease. Chest 1973;63:27—34.&lt;/p&gt;&lt;p&gt;Popper M.S., Bogdonoff M.L., Hughes R.L. Interstitial rheumatoid lung disease. A reassessment and review of the literature. Chest 1972;62:243—50.&lt;/p&gt;&lt;p&gt;Popp W., Rauscher H., Ritschka L. et al. Prediction of interstitial lung involvement in rheumatoid arthritis. The value of clinical data, chest roentgenogram, lung function, and serologic parameters. Chest 1992;102:391—4.&lt;/p&gt;&lt;p&gt;Cervantes-Perez P., Toro-Perez A.H., Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA 1980;243:1715—9.&lt;/p&gt;&lt;p&gt;Fujii M., Adachi S., Shimizu T. et al. Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thome Imaging 1993;8:54—62.&lt;/p&gt;&lt;p&gt;Dawson J.K., Fewins H.E., Desmond J. et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56:622—7.&lt;/p&gt;&lt;p&gt;Rajasekaran B.A., Shovlin D., Lord P., Kelly C.A. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 2001;40:1022—5.&lt;/p&gt;&lt;p&gt;Horton M.R. Rheumatoid arthritis associated interstitial lung disease. Crit Rev Comput Tomogr 2004;45:429—40.&lt;/p&gt;&lt;p&gt;Bongartz T., Nannini C., Medina-Velasquez Y.F. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthr Rheum 2010;62:1583—91.&lt;/p&gt;&lt;p&gt;Jurik A.G., Davidsen D., Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol 1982;11:217—24.&lt;/p&gt;&lt;p&gt;Saag K.G., Kolluri S., Koehnke R.K. et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthr Rheum 1996;39:1711—9.&lt;/p&gt;&lt;p&gt;Banks J., Banks C., Cheong B. et al. An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med 1992;85:795—806.&lt;/p&gt;&lt;p&gt;Gochuico B.R., Avila N.A., Chow C.K. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168:159—66.&lt;/p&gt;&lt;p&gt;Aubart F., Crestani B., Nicaise-Roland P. et al. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with cooccurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 2011;38:979—82.&lt;/p&gt;&lt;p&gt;Anaya J.M., Diethelm L., Ortiz L.A. et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthr Rheum 1995;24:242—54.&lt;/p&gt;&lt;p&gt;Shidara K., Hoshi D., Inoue E. et al. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol 2010;20:280—6.&lt;/p&gt;&lt;p&gt;Bilgici A., Ulusoy H., Kuru O. et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 2005;25:429—35.&lt;/p&gt;&lt;p&gt;Tanaka N., Kim J.S., Newell J.D. et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004;232:81 —91.&lt;/p&gt;&lt;p&gt;Sakaida H. IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease. Ryumachi 1995;35:671—7.&lt;/p&gt;&lt;p&gt;Alexiou I., Germenis A., Koutroumpas A. et al. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008;27:511—3.&lt;/p&gt;&lt;p&gt;Scott T.E., Wise R.A., Hochberg M.C., Wigley F.M. HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. Am J Med 1987;82:765—71.&lt;/p&gt;&lt;p&gt;Charles PJ., Sweatman M.C., Markwick J.R., Maini R.N. HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Dis Markers 1991;9:97—101.&lt;/p&gt;&lt;p&gt;Tanoue L.T. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 1998;19:667—85.&lt;/p&gt;&lt;p&gt;Albano S.A., Santana-Sahagun F., Weisman M.H. Cigarette smoking and rheumatoid arthritis. Sem Arthr Rheum 2001;31:146—59.&lt;/p&gt;&lt;p&gt;Jawaheer D., Gregersen P.K. Rheumatoid arthritis. The genetic components. Rheum Dis Clin North Am 2002;28:1—15.&lt;/p&gt;&lt;p&gt;Klareskog L., Stolt P., Lundberg K. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr Rheum 2006;54:38—46.&lt;/p&gt;&lt;p&gt;Makrygiannakis D., Hermansson M., Ulfgren A.K. et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488—92.&lt;/p&gt;&lt;p&gt;De Rycke L., Nicholas A.P., Cantaert T. et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deаminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthr Rheum 2005;52:2323—30.&lt;/p&gt;&lt;p&gt;Bongartz T., Cantaert T., Atkins S.R. et al. Citrullination in extraarticular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2007;46:70—5.&lt;/p&gt;&lt;p&gt;Stolt P., Bengtsson C., Nordmark B. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835—41.&lt;/p&gt;&lt;p&gt;Ayhan-Ardic F.F., Oken O., Yorgancioglu Z.R. et al. Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 2006;25:213—8.&lt;/p&gt;&lt;p&gt;Gabriel S.E., Crowson C.S., Kremers H.M. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthr Rheum 2003;48:54—8.&lt;/p&gt;&lt;p&gt;Hyland R.H., Gordon D.A., Broder I. et al. A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis. J Rheumatol 1983;10:395—405.&lt;/p&gt;&lt;p&gt;Gabbay E., Tarala R., Will R. et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156(2 Pt 1):528—35.&lt;/p&gt;&lt;p&gt;Sugiyama Y., Ohno S., Kano S. et al. Diffuse panbron-chiolitis and rheumatoid arthritis: a possible correlation with HLA-B54. Intern Med 1994;33:612—4.&lt;/p&gt;&lt;p&gt;Hillarby M.C., McMahon M.I., Grennan D.M. et al. HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 1993;32:794—7.&lt;/p&gt;&lt;p&gt;Michalski J.P., McCombs C.C., Scopelitis E. et al. Alpha1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthr Rheum 1986;29:586—91.&lt;/p&gt;&lt;p&gt;Turesson C., Matteson E.L., Colby TV. et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthr Rheum 2005;52:73—9.&lt;/p&gt;&lt;p&gt;Michel J.J., Turesson C., Lemster B. et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthr Rheum 2007;56:43—57.&lt;/p&gt;&lt;p&gt;Atkins S.R., Turesson C., Myers J.L. et al. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthr Rheum 2006;54:635-41.&lt;/p&gt;&lt;p&gt;Song J.W., Do K.H., Kim M.Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136:23-30.&lt;/p&gt;&lt;p&gt;Ancochea J., Giron R.M., Lopez-Botet M. Production of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages from patients with rheumatoid arthritis and interstitial pulmonary disease. Arch Bronchoreum 1997;33:335-40.&lt;/p&gt;&lt;p&gt;Horie S., Nakada K., Minota S., Kano S. High proliferative potential colony-forming cells (HPP-CFCs) in the peripheral blood of rheumatoid arthritis patients with interstitial lung disease. Scand J Rheumatol 2003;32:273-6.&lt;/p&gt;&lt;p&gt;Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14:272-80.&lt;/p&gt;&lt;p&gt;Kim E.J., Elicker B.M., Maldonado F. et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35:1322-8.&lt;/p&gt;&lt;p&gt;Lee H.K., Kim D.S., Yoo B. et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005;127:2019-27.&lt;/p&gt;&lt;p&gt;Luqmani R., Hennell S., Estrach C. et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.&lt;/p&gt;&lt;p&gt;Roschmann R.A., Rothenberg R.J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthr Rheum 1987;16:174-85.&lt;/p&gt;&lt;p&gt;Rajasekaran A., Shovlin D., Saravanan V. et al. Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. J Rheumatol 2006;33:1250-3.&lt;/p&gt;&lt;p&gt;Provenzano G. Asymptomatic pulmonary involvement in RA. Thorax 2002;57:187-8.&lt;/p&gt;&lt;p&gt;Dawson J.K., Fewins H.E., Desmond J. et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002:61:517-21.&lt;/p&gt;&lt;p&gt;Shannon T.M., Gale M.E. Noncardiac manifestations of rheumatoid arthritis in the thorax. J Thorac Imaging 1992;7:19-29.&lt;/p&gt;&lt;p&gt;McDonagh J., Greaves M., Wright A.R. et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-22.&lt;/p&gt;&lt;p&gt;Metafratzi Z.M., Georgiadis A.N., Ioannidou C.V. et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007;36:338-44.&lt;/p&gt;&lt;p&gt;Akira M., Sakatani M., Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 1999;23:941-8.&lt;/p&gt;&lt;p&gt;Kim E.J., Collard H.R., King T.E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009;136:1397-405.&lt;/p&gt;&lt;p&gt;Okuda Y., Takasugi K., Kurata N., Takahara J. Bronchoalveolar lavage fluid analysis in rheumatoid arthritis. Ryumachi 1993;33:302-9.&lt;/p&gt;&lt;p&gt;Gilligan D.M., O’Connor C.M., Ward K. et al. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 1990;45:591-6.&lt;/p&gt;&lt;p&gt;Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175:705-11.&lt;/p&gt;&lt;p&gt;Yousem S.A., Colby T.V., Carrington C.B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770-7.&lt;/p&gt;&lt;p&gt;Kinoshita F., Hamano H., Harada H. et al. Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respir Med 2004;98:1131-7.&lt;/p&gt;&lt;p&gt;Tsuchiya Y., Takayanagi N., Sugiura H. et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Euro Respir J 2011;37:1411-7.&lt;/p&gt;&lt;p&gt;Pratt D.S., Schwartz M.I., May J.I., Dreisin R.B. Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax 1979;34:587-93.&lt;/p&gt;&lt;p&gt;Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 1988;93:114-8.&lt;/p&gt;&lt;p&gt;Hubbard R., Venn A. The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford) 2002;41:676-9.&lt;/p&gt;&lt;p&gt;Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.&lt;/p&gt;&lt;p&gt;Saravanan V., Kelly C.A. Survival in fibrosing alveolitis associated with rheumatoid arthritis is better than cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 2003;42:603-4.&lt;/p&gt;&lt;p&gt;Malik S., Saravanan V., Kelly C. Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management. Int J Clin Rheum 2012;7:297-308.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
